Israel VC Backs MiNA's Novel SaRNAs In Cancer, And Add-On Therapy Areas

Lead Compound Heading For Phase II

RNA
Single Strand RNA • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Financing

More from Business